Advanced Heart Failure and Transplant Cardiology · Indianapolis, IN
NPI
1407012776
Since 2008
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
8333 Naab Rd Ste 420
Indianapolis, IN, 46260
Phone (317) 338-6666
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,369 services
Medicare patients, 2024
567
Average age 73
Drug cost, 2024
$20.8M
5,879 prescriptions
Company payments, 2025
$40K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashwin K Ravichandran was code 93306 (echocardiography (tte/tee)), 206 times for 201 patients. In total Ashwin K Ravichandran billed 1,369 services in 49 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 206 | 201 | $47.20 | $9,723 |
| 99215 Office E&M - Established | Office | 160 | 115 | $116.85 | $19K |
| 93750 External Electrocardiographic Monitoring | Facility | 112 | 25 | $28.42 | $3,183 |
| 99214 Office E&M - Established | Office | 104 | 85 | $77.24 | $8,033 |
| 99291 Critical Care E&M | Facility | 102 | 24 | $151.90 | $15K |
| 99233 Hospital E&M - Subsequent | Facility | 80 | 40 | $85.67 | $6,854 |
| 99152 Anesthesia | Facility | 65 | 60 | $8.66 | $563 |
| 93451 Percutaneous Transcatheterization | Facility | 63 | 59 | $83.95 | $5,289 |
| 99205 Office E&M - New | Office | 58 | 58 | $151.13 | $8,766 |
| 94618 Pulmonary Function Testing | Office | 31 | 25 | $21.01 | $651 |
| 96160 E&M - Miscellaneous | Office | 29 | 24 | $1.86 | $54.07 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 23 | 21 | $22.75 | $523 |
| 93000 Electrocardiogram | Office | 22 | 21 | $9.44 | $208 |
| 93306 Echocardiography (TTE/TEE) | Office | 22 | 21 | $135.04 | $2,971 |
| 99223 Hospital E&M - Initial | Facility | 22 | 22 | $118.04 | $2,597 |
By year: 2022 $98K for 1,398 services; 2023 $106K for 1,533 services; 2024 $95K for 1,369 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashwin K Ravichandran prescribed most often to Medicare patients was Spironolactone, with 510 prescriptions and refills. In total Ashwin K Ravichandran wrote 5,879 Medicare prescriptions that cost $20.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 510 | 1,259 | 146 | $3,829 |
| Opsumit Macitentan | 465 | 467 | 46 | $5.9M |
| Jardiance Empagliflozin | 340 | 540 | 84 | $310K |
| Entresto Sacubitril/Valsartan | 321 | 580 | 76 | $372K |
| Tyvaso Dpi Treprostinil | 245 | 246 | 17 | $6.2M |
| Furosemide Generic | 214 | 504 | 65 | $888 |
| Metoprolol Succinate Generic | 195 | 451 | 53 | $2,846 |
| Tadalafil Generic | 190 | 212 | 23 | $106K |
| Atorvastatin Calcium Generic | 180 | 417 | 45 | $1,610 |
| Torsemide Generic | 177 | 449 | 58 | $5,187 |
| Eliquis Apixaban | 141 | 330 | 37 | $191K |
| Warfarin Sodium Generic | 135 | 315 | 24 | $980 |
| Adempas Riociguat | 130 | 130 | 12 | $1.8M |
| Rosuvastatin Calcium Generic | 119 | 307 | 38 | $1,589 |
| Tacrolimus Generic | 119 | 248 | 20 | $12K |
Brand drugs: 2,232 claims; generic drugs: 3,647 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashwin K Ravichandran $40K ($40K in general payments such as food, travel and fees) from 11 companies. The largest payer was Merck Sharp & Dohme LLC with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.